A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group (E2211).

Author:

Kunz Pamela L.1,Catalano Paul J.2,Nimeiri Halla3,Fisher George A.4,Longacre Teri A.5,Suarez Carlos J.4,Yao James C.6,Kulke Matthew H.7,Hendifar Andrew Eugene8,Shanks James Christopher9,Shah Manisha H.10,Zalupski Mark11,Schmulbach Edmond L.12,Reidy Diane Lauren13,Strosberg Jonathan R.14,O'Dwyer Peter J.15,Benson Al Bowen16

Affiliation:

1. Stanford University School of Medicine, Stanford, CA;

2. Dana-Farber Cancer Institute, Boston, MA;

3. Robert H. Lurie Cancer Center of Northwestern University, Chicago, IL;

4. Stanford University, Stanford, CA;

5. Stanford University Medical Center, Stanford, CA;

6. University of Texas MD Anderson Cancer Center, Houston, TX;

7. Boston University/Boston Medical Center, Boston, MA;

8. Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA;

9. Health East Cancer Care, Lake Elmo, MN;

10. The Ohio State University Comprehensive Cancer Center, Columbus, OH;

11. University of Michigan, Ann Arbor, MI;

12. The Permanente Medical Group, South San Francisco, CA;

13. Weill Cornell Medical College, New York, NY;

14. H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL;

15. University of Pennsylvania Abramson Cancer Center, Philadelphia, PA;

16. Northwestern Medicine, Chicago, IL;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Cited by 157 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3